CoChat

No correlation between CSF tau protein phosphorylated at threonine 181 with neocortical neurofibrillary pathology in Alzheimer's disease

Buerger, K., Alafuzoff, I., Ewers, M., Pirttila, T., Zinkowski, R., Hampel, H. · 2007 · Brain
Cited by 56

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Sir, We have shown recently that tau protein hyperphosphorylated at threonine 231 (P-tau231P) in cerebrospinal fluid (CSF), a major candidate marker of Alzheimer's disease (AD), correlates with neurofibrillary pathology in the brain of mostly severely demented AD patients (Buerger et al., 2006). In a clinical study, however, it had been reported earlier, that P-tau subtypes perform differently in the discrimination between mild to moderate AD and comparison groups (Hampel et al., 2004). Recently, Engelborghs and colleagues investigated correlations between CSF levels of P-tau phosphorylated at threonine 181 (P-tau181P), another widely used P-tau candidate marker, and Braak NFT and NP stages (Braak and Braak, 1991) and found no associations (Engelborghs et al., 2007). Therefore, we tested whether CSF P-tau181P correlates with neurofibrillary pathology in our previously studied population. Post-mortem assessed parameters were amount of neurofibrillary tangles (NFT), neuritic plaques (NP), neuropil threads (HP-tau load) and P-tau181P concentration in tissue homogenates measured within the brain of 26 AD patients. The study population, materials and methods as well as statistical analyses were identical to our recent report (Buerger et al., 2006). Levels of P-tau181P in CSF and brain homogenates were determined using a commercially available ELISA (Innotest-Phospho-Tau(181P), Innogenetics, Belgium). To compare tau deposits stained by antibodies against phosphorylated tau at threonine 231 and threonine 181 in the brain of AD patients, additional immunohistochemical staining on tissue samples obtained from temporal cortex of all patients included in the study was carried out. Three different tau antibodies were used: monoclonal PHF-TAU clone AT8 (Innogenetics BR-03) that recognizes PHF-tau and the epitope has been shown to contain serine 202; PHF-TAU clone AT180 (Innogenetics BR-07) that recognizes PHF-tau and the epitope has been determined as being threonine 231; and PHF-TAU clone AT270 (Innogenetics BR-08) that recognizes PHF-tau and the epitope has been determined as being threonine 181. All antibodies were used in dilution of 1/500 and the staining was carried out without pretreatments with incubation overnight. Immunoreactivity was estimated semiquantitatively as mild, moderate or severe.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/brain/awm140

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

Metadata

Authors
Buerger, K., Alafuzoff, I., Ewers, M., Pirttila, T., Zinkowski, R., & Hampel, H.
Venue
Brain
Published
2007-10-01
Volume
130
Issue
10
Pages
e82-e82
ISSN
  • 0006-8950 (ISSN-L)
  • 1460-2156
OpenAlex
W2108681415
Cited by
56
References
3
FWCI
3.16
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.